⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8670495 | 0.77 | ALOX5 (0.43) | — | |
| SCHEMBL25162160 | 0.75 | — | — | |
| SCHEMBL19145053 | 0.74 | — | — | |
| SCHEMBL13123466 | 0.74 | — | — | |
| SCHEMBL14218324 | 0.72 | — | — | |
| SCHEMBL3387878 | 0.72 | — | — | |
| SCHEMBL917621 | 0.72 | — | — | |
| SCHEMBL451192 | 0.72 | — | — | |
| SCHEMBL656544 | 0.72 | — | — | |
| SCHEMBL171169 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12378584-B2 | Methionine analogue synthesis | ENGENES BIOTECH GMBH (AT) | 2025-08-05 | — | — | US | claimed |
| EP-3807415-A1 | METHIONINE ANALOGUE SYNTHESIS | Engenes Biotech GmbH (AT) | 2021-04-21 | — | — | EP | claimed |
| WO-2019238725-A1 | METHIONINE ANALOGUE SYNTHESIS | ACIB GMBH - AUSTRIAN CENTRE OF INDUSTRIAL BIOTECHNOLOGY (AT) | 2019-12-19 | — | — | WO | claimed |
| US-12378584-B2 | Methionine analogue synthesis | ENGENES BIOTECH GMBH (AT) | 2025-08-05 | — | — | US | disclosed |
| EP-3861001-B1 | BORON CONTAINING PDE4 INHIBITORS | PFIZER (US) | 2023-12-13 | — | — | EP | disclosed |
| WO-2023190767-A1 | POLYETHER ETHER KETONE DECOMPOSITION METHOD AND NOVEL SUBSTANCE USING STARTING MATERIAL THAT IS DECOMPOSITION PRODUCT OBTAINED BY THIS DECOMPOSITION METHOD | 国立研究開発法人産業技術総合研究所 | 2023-10-05 | — | — | WO | disclosed |
| US-20230148402-A1 | Boron Containing PDE4 Inhibitors | PFIZER INC. (US) | 2023-05-11 | — | — | US | disclosed |
| US-11559538-B2 | Substituted 1,2-oxaborolan-2-ols as PDE4 inhibitors | PFIZER INC. (US) | 2023-01-24 | — | — | US | disclosed |
| EP-3861001-A1 | BORON CONTAINING PDE4 INHIBITORS | Pfizer Inc. (US) | 2021-08-11 | — | — | EP | disclosed |
| CN-113166177-A | Boron-containing PDE4 inhibitors | 辉瑞公司 | 2021-07-23 | — | — | CN | disclosed |
| EP-3807415-A1 | METHIONINE ANALOGUE SYNTHESIS | Engenes Biotech GmbH (AT) | 2021-04-21 | — | — | EP | disclosed |
| EP-1280419-A4 | FURFURYL PROPYL DISULFIDE AS A FLAVORING AGENT AND METHODS FOR PREPARING AND USING SAME | BUSH BOAKE ALLEN INC (US) | 2005-01-19 | — | — | EP | disclosed |
| US-6824805-B2 | ADMIXING INGESTIBLE VEHICLE (MEAT, DAIRY, AND BEVERAGE PRODUCTS) WITH ORGANOLEPTIC PURIFIED FURFURYL PROPYL DISULFIDE FORMED BY REACTING SODIUM FURFURYLTHIOLATE WITH SODIUM PROPYLTHIOSULFATE | BUSH BOAKE ALLEN LTD. | 2004-11-30 | — | — | US | disclosed |
| EP-1280419-A1 | FURFURYL PROPYL DISULFIDE AS A FLAVORING AGENT AND METHODS FOR PREPARING AND USING SAME | Bush Boake Allen Inc. (US) | 2003-02-05 | — | — | EP | disclosed |
| US-20020110628-A1 | Furfuryl propyl disulfide as a flavoring agent and methods for preparing and using same | BUSH BOAKE ALLEN INC. | 2002-08-15 | — | — | US | disclosed |
| WO-2001084959-A1 | FURFURYL PROPYL DISULFIDE AS A FLAVORING AGENT AND METHODS FOR PREPARING AND USING SAME | BUSH BOAKE ALLEN INC. (US) | 2001-11-15 | — | — | WO | disclosed |
| US-5262385-A | Pyrimidine ring containing | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1993-11-16 | — | — | US | disclosed |
| EP-0468766-A1 | Halogen-containing compounds, herbicidal composition containing the same as an active ingredient, and intermediary compounds therefor | Mitsubishi Chemical Corporation (JP) | 1992-01-29 | — | — | EP | disclosed |
| US-4837316-A | ANTIULCER AGENTS | FUJIREBIO KABUSHIKI KAISHA (JP) | 1989-06-06 | — | — | US | disclosed |
| EP-0214823-A2 | Alkylamide derivatives with H2-receptor antagonistic and cytoprotective action | FUJIREBIO KABUSHIKI KAISHA also trading as FUJIREBIO INC. (JP) | 1987-03-18 | — | — | EP | disclosed |